Position in RYTM
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$6,439
+$1,221 QoQ
Shares Held
58
-3.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#270
of 299 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WPG Advisers, LLC holds $865,405 across 47 Biotechnology names. RYTM ranks #17 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
268 | $133,123 | |
| 2 | INCY |
Incyte Corp
|
994 | $112,679 | |
| 3 | EXEL |
Exelixis, Inc.
|
2,066 | $112,411 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
384 | $92,532 | |
| 5 | ARGX |
Argenx SE
|
95 | $88,138 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
980 | $79,879 | |
| 7 | ABVX |
Abivax S.A.
|
432 | $57,568 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
251 | $24,467 |
All Filings in RYTM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,439 | 58 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $5,218 | 60 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,422 | 60 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $5,756 | 57 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $3,601 | 57 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||